Clinical Trial

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL)

Name: False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL) — clinical trial record (NCT07387250)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FLAGSHIP_CHL

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To determine the safety and feasibility of the investigational product to reduce aortic dissection false lumen perfusion.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-27.

Trial Details

NCT Number	NCT07387250
Lead Sponsor	Shape Memory Medical, Inc.
Conditions	Aortic Dissection
Enrollment	15 participants
Start Date	2026-04-01
Primary Completion	2027-04-01 (estimated)
Study Completion	2029-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-19